01.08.2019 MediClin AG  DE0006595101

DGAP-News: MediClin AG: Significant sales increase in all segments


 

DGAP-News: MediClin AG / Key word(s): Half Year Results
MediClin AG: Significant sales increase in all segments

01.08.2019 / 13:36
The issuer is solely responsible for the content of this announcement.


Offenburg, August 1, 2019

Significant sales increase in all segments

In the first half year of 2019, Group sales of MEDICLIN Aktiengesellschaft (MEDICLIN) of EUR 335.4 mill. were 4.3 % or EUR 14.0 mill. higher than in the comparable prior-year's period. Sales in the post-acute segment rose by EUR 10.4 mill. or 5.3 % up to EUR 207.3 mill. The acute segment improved it sales by EUR 3.8 mill. or 3.3 % up to EUR 118.2 mill. Sales in the nursing care business area were close to the prior-year's level.

The reported Group operating result for the first half year of 2019 amounts to EUR 6.1 mill. (1HY 2018: EUR 6.3 mill.). The segment result of the post-acute segment came out to EUR 9.4 mill. (1HY 2018: EUR 7.6 mill.) and the segment result of the acute segment came out to EUR -1.3 mill. (1HY 2018: EUR 1.2 mill.).

In the first six months of 2019 gross investments amounted to EUR 21.7 mill. (1HY 2018: EUR 19.7 mill.), pertaining mainly to the reconstruction and expansion of clinics and the acquisition of medical equipment. Capital expenditure is thus in line with the annual budget. Cash and cash equivalents as of 30 June 2019 amounted to EUR 19.3 mill. (31.12.2018: EUR 33.8 mill.). On average MEDICLIN employed about 10.244 employees in the first half year of 2019.

Outlook

The business performance to date and the outlook for the 3rd quarter, which is traditionally the strongest season in terms of sales and earnings, indicate that the Group will reach its targets for the 2019 financial year.

In the second half of 2019, the Management Board expects growing sales for the Group and a significantly better Group operating result, despite rising staff costs and raw materials and consumables used.

The Management Board expects that due to the legislator's regulatory requirements, in particular expenditures for qualified staff will increase significantly in the current financial year.

The interim report as of 30 June 2019 is available on the homepage of MEDICLIN in German and English from today on. www.mediclin.de

/

About MEDICLIN AG (Ticker: MED; WKN: 659 510)

MEDICLIN owns 36 clinics, seven nursing care facilities, two in-home elder care services and ten medical care centres. The Group has about 8,350 beds and a headcount of more than 10,000. With its strong network, MEDICLIN can offer its patients integrated care from the first visit to the doctor to surgery, post-operative rehabilitation and follow-up care at home. Doc-tors, therapists and nurses work together closely to achieve the best results. MEDICLIN plans the care of persons in need in accordance with their individual requirements and personal needs, either at home or in a nursing care facility.

MEDICLIN - A company of the Asklepios Group.



01.08.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-326
Fax: +49 (0)781 488-184
E-mail: [email protected]
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 850399

 
End of News DGAP News Service

850399  01.08.2019 

fncls.ssp?fn=show_t_gif&application_id=850399&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 609,08 645,11 673,09 659,86 673,14 704,70 730,07
EBITDA1,2 27,01 37,35 93,58 77,50 85,22 90,92 98,73
EBITDA-Marge3 4,43 5,79 13,90 11,74 12,66 12,90
EBIT1,4 6,62 15,06 22,41 0,15 11,56 19,52 12,72
EBIT-Marge5 1,09 2,33 3,33 0,02 1,72 2,77 1,74
Jahresüberschuss1 3,96 7,76 9,68 -0,04 1,49 9,72 -10,72
Netto-Marge6 0,65 1,20 1,44 -0,01 0,22 1,38 -1,47
Cashflow1,7 19,34 29,77 69,59 118,69 81,97 34,64 78,00
Ergebnis je Aktie8 0,08 0,16 0,20 -0,19 0,03 0,20 -0,23
Dividende8 0,05 0,05 0,05 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Mediclin
WKN Kurs in € Einschätzung Börsenwert in Mio. €
659510 2,740 Halten 130,15
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
10,54 19,26 0,57 20,60
KBV KCV KUV EV/EBITDA
0,66 1,67 0,18 1,52
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 06.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
02.05.2024 31.07.2024 04.11.2024 26.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
6,24% 0,66% 0,00% -11,04%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu MediClin AG  ISIN: DE0006595101 können Sie bei EQS abrufen


Pflegeeinrichtungen , 659510 , MED , XETR:MED